I
n a strategic move, King Street Properties has acquired 359 Allston Street, a prime life science property in Cambridge's vibrant East End. The acquisition was facilitated by Newmark's expert team, led by Robert Griffin and Edward Maher, who represented the undisclosed seller and secured the deal.

    Occupied by Vaxess Technologies, a rapidly growing biotech firm, the building boasts an efficient floor plate and exclusive outdoor spaces, making it an ideal flagship for life science companies in Cambridge. The property's highly sought-after location is just minutes from Kendall Square, the epicenter of Boston's life science industry, and within walking distance to Massachusetts Institute of Technology.

    "This acquisition aligns perfectly with our long-term vision," said Tyson Reynoso, Managing Director/Partner at King Street Properties. "We appreciate Newmark's support in making this transaction a success." The property offers dynamic space for early-stage companies, solidifying East Cambridge as the premier life science location in the country.

    With over 20 years of experience specializing in life sciences properties, King Street owns and operates 6.5 million square feet of real estate across major life science markets nationwide.